Alps Advisors Inc. lowered its position in shares of Teleflex Inc. (NYSE:TFX) by 3.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,798 shares of the medical technology company’s stock after selling 88 shares during the period. Alps Advisors Inc.’s holdings in Teleflex were worth $496,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Atlanta Capital Management Co. L L C raised its stake in shares of Teleflex by 42.1% in the first quarter. Atlanta Capital Management Co. L L C now owns 1,830,995 shares of the medical technology company’s stock valued at $287,484,000 after buying an additional 542,610 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Teleflex by 120.7% in the first quarter. Wellington Management Group LLP now owns 761,800 shares of the medical technology company’s stock valued at $119,610,000 after buying an additional 416,696 shares in the last quarter. USS Investment Management Ltd bought a new stake in shares of Teleflex during the first quarter valued at approximately $58,057,000. Norges Bank bought a new stake in shares of Teleflex during the fourth quarter valued at approximately $43,143,000. Finally, Renaissance Technologies LLC raised its stake in shares of Teleflex by 279.6% in the first quarter. Renaissance Technologies LLC now owns 154,100 shares of the medical technology company’s stock valued at $24,195,000 after buying an additional 113,500 shares in the last quarter. 93.77% of the stock is currently owned by institutional investors.
Teleflex Inc. (NYSE:TFX) traded down 0.51% during trading on Monday, reaching $167.19. 288,248 shares of the company’s stock were exchanged. Teleflex Inc. has a 12-month low of $122.14 and a 12-month high of $188.79. The stock’s 50-day moving average is $178.50 and its 200-day moving average is $169.97. The company has a market cap of $7.36 billion, a P/E ratio of 29.68 and a beta of 0.83.
Teleflex (NYSE:TFX) last posted its earnings results on Thursday, July 28th. The medical technology company reported $1.89 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.15. The business had revenue of $473.60 million for the quarter, compared to analysts’ expectations of $468.40 million. Teleflex had a net margin of 14.89% and a return on equity of 15.59%. The business’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.42 EPS. Analysts predict that Teleflex Inc. will post $7.33 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Thursday, September 15th. Shareholders of record on Monday, August 15th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.81%. The ex-dividend date was Thursday, August 11th. Teleflex’s dividend payout ratio is currently 24.11%.
Several equities analysts have recently weighed in on the stock. Leerink Swann lifted their target price on shares of Teleflex from $183.00 to $190.00 and gave the stock a “market perform” rating in a research note on Friday, July 29th. Jefferies Group lifted their target price on shares of Teleflex from $157.00 to $185.00 and gave the stock a “hold” rating in a research note on Friday, July 29th. Barclays PLC lifted their target price on shares of Teleflex from $183.00 to $185.00 and gave the stock an “overweight” rating in a research note on Friday, July 29th. Finally, Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $192.00 target price for the company in a research note on Wednesday, June 29th. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $171.33.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Inc. (NYSE:TFX).
Receive News & Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.